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Phellinus linteus (PL) has traditionally been used as a medicinal mushroom in 
some countries such as China, Japan and Korea. It was found the fruiting body of PL is 
rich in bioactive phytochemicals. The antioxidant property of PL has been associated in 
preventing cancer progression. It is also suggested that the polysaccaharides component 
of PL is responsible for antitumor and immuno-modulatory effect in vivo and in vitro. 
However, the mechanism of the inhibition effect and invasive behavior of PL on cancer 
such as LS 174T colonic carcinoma is not well elucidated. PL is suggested to be able to 
inhibit cancer cell adhesion and invasion of the extracellular matrix. Therefore, it is 
believed that PL can exert antitumor effect by initiating apoptosis and cell cycle blockade 
in cancerous cells.  
Colon cancer is an emerging health problem in Asia due to change in dietary 
habits. In this study, the effect of PL on cell cycle and its association with antioxidant 
activity of LS 174T cells were investigated. Two different doses (50 μg/ml and 300 
μg/ml) of PL extract that has high antioxidant activity (unit of 3 TEAC) were added to LS 
174T cells with or without 200 μM H2O2 challenge. Catalase activity, cell viability and 
cell cycle of the cells were determined at stationary phase of cell growth. 
It was found that treatment of PL alone showed decreased (p<0.01) catalase 
activity when compared to control. Oxidative stress challenge (200 μM H2O2) increased 
catalase activity (p<0.01) compared to control. However, addition of PL reduced the 
catalase activity (p<0.01) but not to control level. This effect was not dose-dependent in 
which both PL doses showed similar catalase activity.  
Cells treated with PL alone or 50 μg/ml PL + 200 μM H2O2 or 300 μg/ml PL + 
200 μM H2O2 showed comparable cell viability as control and higher (p<0.01) cell 
viability than 200 μM H2O2 treated cells. However, the difference was not significant 
between two PL doses. 
Treatment of 50 μg/ml and 300 μg/ml PL showed increased (p<0.05) cell 
apoptosis when compared to control. However, the difference was not significant 
between the two PL doses. It was noted G2/M phase elevated (p<0.05) when the cells 
were treated with 300 μg/ml PL only.  
Cells challenged with 200 μM H2O2 increased apoptosis compared to control. 
However addition 50 μg/ml or 300 μg/ml PL showed reduced (p<0.05) cell apoptosis but 
not to control level. Also, a decrease (p<0.05) in G2/M phase for cells treated with 
300μg/ml PL + 200 μM H2O2 was recorded compared to 200 μM H2O2 treated cells.  
Our findings indicate PL alone could induce cell apoptosis. It is plausible higher dose of 
PL can effectively reduce cell apoptosis and cell cycle arrest at G2/M phase by its 
antioxidant effect. Thus, PL interacts with LS 174T cells effectively under oxidative 
stress to maintain homeostasis: a possible mechanism of hormesis. 
